tiprankstipranks
Trending News
More News >
China Lilang Ltd. (HK:1234)
:1234
Advertisement

China Lilang Ltd. (1234) AI Stock Analysis

Compare
1 Followers

Top Page

HK:1234

China Lilang Ltd.

(Frankfurt:1234)

Rating:74Outperform
Price Target:
HK$4.00
▲(7.24% Upside)
China Lilang Ltd. scores well due to its strong financial performance and attractive valuation, with a low P/E ratio and high dividend yield. However, technical indicators suggest a neutral market sentiment, and the lack of earnings call data and corporate events limits additional insights. The decline in revenue and free cash flow growth presents potential risks that could impact future performance.

China Lilang Ltd. (1234) vs. iShares MSCI Hong Kong ETF (EWH)

China Lilang Ltd. Business Overview & Revenue Model

Company DescriptionChina Lilang Ltd. (1234) is a leading menswear company based in China. It primarily engages in the design, manufacturing, and retail of a wide range of apparel products. The company's core products include business and casual menswear, such as suits, jackets, shirts, and trousers, marketed under the 'LILANZ' and 'L2' brands. With a strong focus on quality and style, China Lilang has established a significant presence in the Chinese menswear market.
How the Company Makes MoneyChina Lilang Ltd. makes money primarily through the sale of its menswear products. The company's revenue model is centered around its extensive retail network, which includes a combination of self-operated stores and franchised outlets across China. Key revenue streams include direct sales from its branded stores and wholesale distribution to franchisees. The company also benefits from its strategic partnerships with suppliers and designers, which help in maintaining the quality and appeal of its product offerings. Additionally, China Lilang invests in marketing and brand-building initiatives to strengthen its market position and drive sales growth.

China Lilang Ltd. Financial Statement Overview

Summary
China Lilang Ltd. maintains strong profitability and a stable balance sheet with low leverage. However, a decline in revenue growth and free cash flow growth poses challenges for future growth and profitability.
Income Statement
75
Positive
China Lilang Ltd. demonstrates strong profitability with consistent gross and net profit margins. The gross profit margin for 2024 is 47.66% and the net profit margin is 12.63%, indicating effective cost management. However, the revenue growth rate from 2023 to 2024 is only 3.00%, showing a slowdown which could impact future profitability. Despite a decrease in EBIT margin to 15.14%, the company's EBITDA margin remains healthy at 24.49%.
Balance Sheet
80
Positive
The company's balance sheet shows a solid equity base with an equity ratio of 58.74% in 2024, reflecting financial stability. The debt-to-equity ratio is 0.33, indicating low leverage and reduced financial risk. However, the return on equity (ROE) has decreased to 11.44%, suggesting reduced efficiency in generating profits from shareholders' equity.
Cash Flow
70
Positive
China Lilang Ltd. has a stable cash flow situation with a free cash flow to net income ratio of 0.88, indicating good conversion of net income to free cash. However, the free cash flow growth rate is -58.20% from 2023 to 2024, highlighting a significant decline that could challenge future investments or debt servicing. The operating cash flow to net income ratio of 1.14 shows strong operational cash generation.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.65B3.54B3.09B3.38B2.68B
Gross Profit1.74B1.71B1.42B1.42B1.20B
EBITDA893.87M913.55M794.03M795.27M787.26M
Net Income460.80M530.43M448.06M468.13M557.24M
Balance Sheet
Total Assets6.85B6.50B5.48B5.01B5.01B
Cash, Cash Equivalents and Short-Term Investments1.66B1.08B960.11M1.57B1.74B
Total Debt1.32B1.27B568.45M233.87M123.93M
Total Liabilities2.80B2.54B1.70B1.33B1.36B
Stockholders Equity4.03B3.97B3.78B3.67B3.65B
Cash Flow
Free Cash Flow403.85M966.59M273.38M282.47M511.94M
Operating Cash Flow527.30M1.10B653.69M598.55M773.29M
Investing Cash Flow-306.29M-1.21B-1.18B-280.05M-190.78M
Financing Cash Flow-471.60M227.99M-90.43M-482.92M-590.33M

China Lilang Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.73
Price Trends
50DMA
3.73
Negative
100DMA
3.66
Positive
200DMA
3.73
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
44.05
Neutral
STOCH
15.04
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1234, the sentiment is Negative. The current price of 3.73 is below the 20-day moving average (MA) of 3.78, below the 50-day MA of 3.73, and above the 200-day MA of 3.73, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.05 is Neutral, neither overbought nor oversold. The STOCH value of 15.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1234.

China Lilang Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
HK$17.43B11.1413.55%4.17%13.03%22.23%
75
Outperform
$53.13B13.5822.98%5.71%10.50%10.34%
74
Outperform
€4.42B9.6710.67%9.49%3.23%-21.82%
73
Outperform
HK$1.02B31.732.21%1.19%-14.05%20.05%
71
Outperform
HK$844.47M6.136.38%4.10%7.08%190.74%
69
Neutral
$2.91B12.992.27%4.24%-4.65%
56
Neutral
HK$25.46B5.06-2.69%5.60%-0.43%-53.15%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1234
China Lilang Ltd.
3.73
0.02
0.67%
HK:2298
Cosmo Lady (China) Holdings Co. Ltd.
0.38
0.14
58.33%
HK:2232
Crystal International Group Limited
6.11
2.96
93.97%
HK:2030
Cabbeen Fashion Limited
1.51
0.13
9.42%
HK:3998
Bosideng International Holdings
4.79
1.10
29.88%
HK:3818
China Dongxiang (Group) Co
0.50
0.22
82.66%

China Lilang Ltd. Corporate Events

China Lilang Ltd. Releases 2025 Interim Financial Results
Aug 12, 2025

China Lilang Ltd. has announced its unaudited consolidated results for the first half of 2025, revealing its financial performance and operational outcomes. The interim results, which comply with the Hong Kong Stock Exchange’s listing requirements, provide stakeholders with insights into the company’s current market positioning and potential future developments.

The most recent analyst rating on (HK:1234) stock is a Buy with a HK$4.85 price target. To see the full list of analyst forecasts on China Lilang Ltd. stock, see the HK:1234 Stock Forecast page.

China Lilang Schedules Board Meeting to Review Interim Results
Jul 31, 2025

China Lilang Limited has announced a board meeting scheduled for August 12, 2025, to approve the unaudited consolidated interim results for the first half of the year and to consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.

The most recent analyst rating on (HK:1234) stock is a Buy with a HK$4.96 price target. To see the full list of analyst forecasts on China Lilang Ltd. stock, see the HK:1234 Stock Forecast page.

China Lilang Reports Growth in Retail Sales for 2025
Jul 10, 2025

China Lilang Ltd. reported mid-to-high-single-digit growth in retail sales for its LILANZ products in both the second quarter and the first half of 2025 compared to the same periods in 2024. This operational update, based on preliminary unaudited data, suggests a positive trend in the company’s retail performance, although it does not fully represent the group’s overall financial results. Stakeholders are advised to exercise caution as the information may be subject to change.

The most recent analyst rating on (HK:1234) stock is a Buy with a HK$4.96 price target. To see the full list of analyst forecasts on China Lilang Ltd. stock, see the HK:1234 Stock Forecast page.

China Lilang Appoints New Independent Directors
Jun 27, 2025

China Lilang Limited has announced the appointment of Prof. Liao Jianwen and Prof. Jiang Zhan as independent non-executive directors. Both professors have confirmed their independence according to the Listing Rules, with no financial or other interests in the company’s business, ensuring their impartiality in governance.

The most recent analyst rating on (HK:1234) stock is a Buy with a HK$4.85 price target. To see the full list of analyst forecasts on China Lilang Ltd. stock, see the HK:1234 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 13, 2025